CULLINAN THERAPEUTICS, INC. Shares Outstanding (Cover Page)
CULLINAN THERAPEUTICS, INC. (CGEM) had Shares Outstanding (Cover Page) of 64.35 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 64.35M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 61.46M shares.
- 2026-02-23: Entity Common Stock, Shares Outstanding 60.53M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 59.08M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 64.35M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 61.46M shares 10-Q · filed 2026-05-07 |
| 2026-02-23 | 60.53M shares 10-K · filed 2026-03-10 |
| 2025-10-31 | 59.08M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 59.07M shares 10-Q · filed 2025-08-07 |
| 2025-04-30 | 59.01M shares 10-Q · filed 2025-05-08 |
| 2025-02-21 | 58.51M shares 10-K · filed 2025-02-27 |
| 2024-10-31 | 58.23M shares 10-Q · filed 2024-11-07 |
| 2024-07-31 | 57.98M shares 10-Q · filed 2024-08-08 |
| 2024-05-08 | 57.63M shares 10-Q · filed 2024-05-15 |
| 2024-03-01 | 43.07M shares 10-K · filed 2024-03-14 |
| 2023-10-31 | 42.78M shares 10-Q · filed 2023-11-08 |
| 2023-07-31 | 42.73M shares 10-Q · filed 2023-08-10 |
| 2023-05-01 | 39.36M shares 10-Q · filed 2023-05-11 |
| 2023-03-01 | 39.33M shares 10-K · filed 2023-03-09 |
| 2022-11-04 | 45.77M shares 10-Q · filed 2022-11-14 |
| 2022-07-31 | 45.61M shares 10-Q · filed 2022-08-10 |
| 2022-04-25 | 44.78M shares 10-Q · filed 2022-05-16 |
| 2022-03-01 | 44.61M shares 10-K · filed 2022-03-17 |
| 2021-11-02 | 43.68M shares 10-Q · filed 2021-11-09 |
| 2021-07-26 | 43.54M shares 10-Q · filed 2021-08-10 |
| 2021-04-30 | 43.52M shares 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |